Wilfried De Backer

Fluidda is a medical technology company and contract research organization (CRO) specializing in Functional Respiratory Imaging (FRI). The company's proprietary platform combines high-resolution computed tomography (HRCT) scans with computational fluid dynamics (CFD) to provide detailed, three-dimensional visualizations of lung structure and function. This technology offers more sensitive and regional data compared to traditional pulmonary function tests like spirometry, making it a valuable tool for respiratory drug development. Fluidda collaborates with major pharmaceutical companies to provide imaging biomarkers for clinical trials in indications such as COPD, asthma, and idiopathic pulmonary fibrosis. Founded by Professor Wilfried De Backer, the company is a leader in the application of personalized medicine to respiratory care, helping to optimize drug delivery and patient stratification.